Data / Form D filings / Relation Therapeutics Inc.
Relation Therapeutics Inc.: Form D filings
Relation Therapeutics Inc., a biotechnology company in Miami Beach, FL, filed 5 Form D notices with the SEC between 2021 and 2025. The latest, on December 9, 2025, reports $36.2 million sold of a $36.2 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1000 South Pointe Dr., PH 1605, Miami Beach, FL, 33319
- Phone
- 4477-1720-7218
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1876828
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | New notice | $36,175,000 | $36,175,000 | 5 | Nov 21, 2025 | sec.gov | |
| Dec 10, 2024 | New notice | $15,000,000 | $15,000,000 | 1 | Nov 22, 2024 | sec.gov | |
| Jan 19, 2024 | New notice | $51,651,846 | $40,251,846 | $11,400,000 | 10 | Jan 9, 2024 | sec.gov |
| Jun 3, 2022 | New notice | $16,000,000 | $16,000,000 | 8 | May 19, 2022 | sec.gov | |
| Aug 10, 2021 | New notice | $9,000,000 | $9,000,000 | 10 | Jul 28, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Roblin | Executive Officer, Director | |
| Charles Roberts | Director | |
| Jason Benjamin Pontin | Director | |
| Jim Benjamin Mellon | Director | |
| Christine Benjamin Aylward | Director | |
| Casey Benjamin Swerner | Executive Officer |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Dec 8, 2025 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Relation Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.